United States Food and Drug Administration Approves Aridol

Links shared publicly online about this topic.

  • 808
    total visits

United States Food and Drug Administration Approves Aridol

drugs.com

Aridol (mannitol inhalation powder) is a bronchial challenge test to help in the correct diagnosis and assessment of asthma. Aridol information includes news, clinical trial results and side effects.

View full resource at drugs.com

Tags: Asthma, Lung, Diet and Nutrition, Drug, Clinical Trial, FDA, News

  • Share

Most Recently Shared on October 11, 2010 at 11:12 pm By:

Drugs_Devices Drugs and Devices OW

United States Food and Drug Administration Approves Aridol: Sydney, Australia - 6 October 2010 - Pharmaceuti... http://bit.ly/d3KPYi #drug

2 years ago...

Botox Treatments for Urinary Incontinence in Seniors | The Intentional Caregiver

takingcareofthefolks.com — “Botox Treatments for Urinary Incontinence in Seniors The United States Food and Drug Administration approvedView full resource at takingcareofthefolks.com

  • View Related
  • Share

Most Recently Shared on April 21, 2012 at 2:03 am By:

Government ponders heart safety trials for obesity drugs - Yahoo! News

news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on their path to approval. An advisory panel to the Food and Drug Administration will discuss this week whether regulators should mandate such trials before the drugs can be marketed in the United States. ...View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 7:06 pm By:

HealthTrendster HealthTrendster Health Executive

Government ponders heart safety trials for obesity drugs - WASHINGTON (Reuters) - Health regulators are asking for a... http://t.co/MSNblCsb

2 months ago...

Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro

news-medical.net — “Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 7:14 pm By:

NewsMedical News-Medical.Net Health News

Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro: Teva Pharmaceutical... http://t.co/XKefLRHt

3 months ago...

EffRx receives FDA approval for BINOSTO to treat osteoporosis

news-medical.net — “EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 4:26 am By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: EffRx receives FDA approval for BINOSTO to treat osteoporosis: EffRx Pharmaceuticals SA today ann... http://t.co/oNs9QvFc

3 months ago...

FDA approves new supplies of drugs that are facing shortages

news-medical.net — “The United States Food and Drugs Administration (FDA) have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been concerning patients and families particularly of the children with leukemia. But there are currently 283 separate prescription drugs in short supply or unavailable nationwide, and regulators and manufacturers say shortages are a long-term problem that will continue to scare patients and doctors.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 22, 2012 at 11:29 pm By:

Ovarian_Cancer_ News-Medical.Net Health News

Ovarian Cancer News: FDA approves new supplies of drugs that are facing shortages: The United States Food and Dr... http://t.co/655iWVM7

3 months ago...

Bangor man is second person in the US to get neurostimulation device implanted to stop pain. - latimes.com

latimes.com — “St. Luke's Hospital: Jeff Hardick is second person in the United States to have neurostimulation device implanted after it receiving approval by the U.S. Food and Drug Administration in November.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on January 9, 2012 at 5:37 pm By:

DalePfrimmer Dale Pfrimmer, RN Nurse

Bangor man second in U.S. to get anti-pain implant http://t.co/ExlhxAn3 via @LATimes

5 months ago...

A landmark for children's health - Houston Chronicle

chron.com — “Recently, the United States Food and Drug Administration granted humanitarian device exemption for the Berlin Heart EXCOR Pediatric Ventricular Assist Device - the only pediatric mechanical circulatory support device designed specifically for infants and small children. [...] FDA approval, the device was only available to children in the U.S. through compassionate use solicitation, on a case-by-case basis. Small children awaiting heart transplantation where donor availability is limited face a wView full resource at chron.com

  • View Related
  • Share

Most Recently Shared on January 3, 2012 at 4:56 pm By:

hamtmclibrary TMC Library Medical Education

RT @bcmhouston: Landmark event: FDA approves Berlin Heart for children with heart failure. http://t.co/NOpFIr10

5 months ago...

Belotero Balance – Another Restylane? » Truth in Cosmetic Surgery

cosmeticsurgerytruth.com — “Merz Aesthetics announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Belotero Balance for the correction of...View full resource at cosmeticsurgerytruth.com

  • View Related
  • Share

Most Recently Shared on November 30, 2011 at 3:48 pm By:

drdisaia John Di Saia MD Surgeon, Plastic Surgeon, Physician, and Doctor

Cos Surg Truth Blog Belotero Balance – Another Restylane?: Merz Aesthetics announced that the United States (U... http://t.co/F0j0ta1O

6 months ago...

The HPV Vaccine: Access and Use in the U.S. - Kaiser Family Foundation

kff.org — “The Food and Drug Administration has approved two vaccines against infection by certain strains of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Initially, the vaccines were recommended only for girls and young women, but in 2011 the Centers for Disease Control and Prevention broadened them to include boys and young men. The fact sheet discusses HPV and cancers related to the virus, use of the HPV vaccines for both females and males, and insuranView full resource at kff.org

  • View Related
  • Share

Most Recently Shared on November 22, 2011 at 6:36 pm By:

HealthyAmerica1 TFAH Health Organization

HPV Vaccine Fact Sheet Discusses New Recommendation for Vaccinating Boys via KFF: http://t.co/4DpKQQdp

6 months ago...

FDA Approves First Umbilical Cord Blood Product - Yahoo! News

news.yahoo.com — “From Yahoo! News: FRIDAY, Nov. 11 (HealthDay News) -- The first product in the United States that uses human umbilical cord stem cells to treat disorders of the hematopoietic (blood-forming) system has been approved by the Food and Drug Administration.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on November 12, 2011 at 7:02 am By:

KimberlyYoungRN Kimberly Young Nurse

FDA Approves First Umbilical Cord Blood Product - Yahoo! News http://t.co/ybfvM2FN via @YahooNews

7 months ago...

Watson receives FDA approval for generic Kadian ANDA

news-medical.net — “Watson Pharmaceuticals, Inc. today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for morphine sulfate extended-release capsules USP, the generic equivalent of Actavis' Kadian.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 11, 2011 at 5:17 am By:

Medicare_News News-Medical.Net Health News

Medicare News: Watson receives FDA approval for generic Kadian ANDA: Watson Pharmaceuticals, Inc. today announce... http://t.co/bq3BVrMo

7 months ago...

Pioneering Stroke Spasticity Expert Welcomes FDA Approval of Botox® To Treat Upper Limb Spasticity Following Stroke - Wake Forest Baptist Medical Center

wakehealth.edu — “The announcement by the Food and Drug Administration (FDA) that it has approved Botox® (onabotulinumtoxinA) to treat upper limb spasticity (excessive muscle tightness) following a stroke is great news for the millions of stroke survivors in the United States, said Allison Brashear, M.D., professor and chair of the Department of Neurology at WFUBMC.View full resource at wakehealth.edu

  • View Related
  • Share

Most Recently Shared on September 13, 2011 at 8:07 pm By:

wfubmc wfubmc Hospital

Dr. Brashear led a research study that resulted in a new treatment method for upper limb spasticity: Botox http://t.co/ihgvjiS

9 months ago...

Allergan gets FDA nod for use of Botox in urinary incontinence

news-medical.net — “Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 10:18 pm By:

NewsMedical News-Medical.Net Health News

Allergan gets FDA nod for use of Botox in urinary incontinence: Allergan Inc. has received United States Food an... http://t.co/ANHoTem

9 months ago...

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

news-medical.net — “Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 10:30 am By:

Urology_Wisdom Urology & Nephrology OW Health

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence: Allergan, Inc. today announced the... http://t.co/l4VjvY6

9 months ago...

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

news-medical.net — “Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 5:25 am By:

Obesity_News News-Medical.Net Health News

Obesity News: FDA approves Allergan's BOTOX to treat specific form of urinary incontinence: Allergan, Inc. tod... http://t.co/PUWqG8S

9 months ago...

Advertisement